Inventor · disambiguated record
Oliver Yoa-Pu Hu
Also filed as: HU OLIVER Y · HU OLIVER YOA-PU
16 granted patents·11 pending applications·260 citations·filing 1996–2024
93Inventor score
Files withSINEW PHARMA INC6HU OLIVER YOA-PU5AVALON HEPAPOC LTD3NATIONAL DEFENSE EDUCATION AND RES FOUNDATION3NAT SCIENCE COUNCIL2
Top patents by PatentIndex Score
27 records- 0184US6703398B2Orally administered analgesic compositions containing nalbuphineHU OLIVER YOA-PU·Filed 2001·Granted Mar 9, 2004·17 cites·14 claims
- 0284US6225321B1Long analgesic acting nalbuphine polyester derivative and method of useFiled 1997·Granted May 1, 2001·58 cites·17 claims
- 0381US2024335404A1Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseasesSINEW PHARMA INC·Filed 2024·Application pending·0 cites
- 0480US6544954B1Stable galactose injection solutionsHU OLIVER YOA-PU·Filed 2002·Granted Apr 8, 2003·12 cites·13 claims
- 0579US10456371B2Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseasesSINEW PHARMA INC·Filed 2016·Granted Oct 29, 2019·1 cites·34 claims
- 0679US6004969ATransdermal delivery of buprenorphine preparationsNAT SCIENCE COUNCIL·Filed 1997·Granted Dec 21, 1999·54 cites·6 claims
- 0779US5807115ADissolution apparatus simulating physiological gastrointestinal conditionsFiled 1996·Granted Sep 15, 1998·56 cites·10 claims
- 0875US6680067B2Controlled-release pharmaceutical preparation containing nalbuphine and a process for preparing the sameHU OLIVER YOA-PU·Filed 2001·Granted Jan 20, 2004·6 cites·19 claims
- 0974US12083088B2Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseasesSINEW PHARMA INC·Filed 2022·Granted Sep 10, 2024·0 cites·81 claims
- 1074US11534416B2Hepatotoxicity-free pharmaceutical composition containing acetaminophen drugsNATIONAL DEFENSE EDUCATION AND RES FOUNDATION·Filed 2019·Granted Dec 27, 2022·1 cites·21 claims
- 1171US2023082397A1Acetaminophen compound composition without side effect to liverNATIONAL DEFENSE EDUCATION AND RES FOUNDATION·Filed 2022·Application pending·0 cites
- 1271US2013184227A1Cytochrome P450 2C9 InhibitorsHU OLIVER YOA-PU·Filed 2009·Application pending·0 cites
- 1368US11285123B2Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseasesSINEW PHARMA INC·Filed 2019·Granted Mar 29, 2022·0 cites·62 claims
- 1464US2014343116A1Cytochrome p450 2c9 inhibitorsNAT DEFENSE MEDICAL CT·Filed 2014·Application pending·0 cites
- 1562US5686423ADi-and tri-peptide mimetic compounds for Parkinson's diseaseDEPARTMENT OF HEALTH THE EXECU·Filed 1996·Granted Nov 11, 1997·33 cites·16 claims
- 1662US2024344108A1Galactose rapid quantitative detection system and use thereofAVALON HEPAPOC LTD·Filed 2024·Application pending·0 cites
- 1761US7169763B2Cytochrome P450 3A inhibitors and enhancersHU OLIVER YOA-PU·Filed 2002·Granted Jan 30, 2007·1 cites·4 claims
- 1860US2006069042A1Cytochrome P450 2C9 inhibitorsHU OLIVER Y·Filed 2004·Application pending·0 cites
- 1959US2004171631A1Orally administered analgesic compositions containing nalbuphineFiled 2004·Application pending·0 cites
- 2058US6162459AAcyclovir transdermal delivery systemNAT SCIENCE COUNCIL·Filed 1997·Granted Dec 19, 2000·19 cites·2 claims
- 2155US10976322B2Galactose oral composition and use thereofAVALON HEPAPOC LTD·Filed 2018·Granted Apr 13, 2021·0 cites·15 claims
- 2246US2021008101A1Methods and compositions for preventing, reducing or eradicating toxicity caused by acetaminophen (apap)SINEW PHARMA INC·Filed 2019·Application pending·0 cites
- 2338US2020069675A1Pharmaceutical preparations of sebacoyl dinalbuphine and acetaminophen and methods for treating painINT EDUCATION FOUNDATION·Filed 2018·Application pending·0 cites
- 2438US2020123589A1Galactose rapid quantitative detection system and use thereofAVALON HEPAPOC LTD·Filed 2018·Application pending·0 cites
- 2531US10925854B2Methods and compositions for preventing or treating fatty liver, protecting liver function or ameliorating liver diseases caused by fatty liver or other associated disordersSINEW PHARMA INC·Filed 2016·Granted Feb 23, 2021·0 cites·15 claims
- 2629US2018325840A1Compositions and methods for preventing or treating fatty pancreas or ameliorating pancreas diseases caused by fatty pancreas, diabetes mellitus or other related disordersNATIONAL DEFENSE EDUCATION AND RES FOUNDATION·Filed 2016·Application pending·0 cites
- 2725US6022558ATransdermal preparations of oxicamsFiled 1997·Granted Feb 8, 2000·2 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Oliver Yoa-Pu Hu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →